Personalized vaccine plus immunotherapy shows promise for tough lung cancer
Disease control
Completed
This study tested whether adding a personalized dendritic cell vaccine to the immunotherapy drug atezolizumab could help people with extensive-stage small cell lung cancer stay stable longer after initial chemotherapy. Twenty participants received standard chemo plus atezolizumab…
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC